Skip to main content
Clinical Trials/NCT00458770
NCT00458770TerminatedNot Applicable

Study of Hypothalamic Metabolism in Spontaneous Cluster Headache Attacks

Assistance Publique Hopitaux De Marseille1 site in 1 country1 target enrollmentStarted: May 1, 2009Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
1
Locations
1
Primary Endpoint
To confirm the existence of a hypothalamic promoter at the origin of Spontaneous Cluster Headache Attacks

Study Overview

Brief Summary

Cluster headache is characterized by unilateral excruciating head pain and autonomic dysfunction. Hypothalamic overactivity was observed in nitrate-induced cluster-headache and in only one case of spontaneous cluster headache 'Sprenger et al, 2004). This prompted the application of hypothalamic deep brain stimulation. The aim of this data is to precise the localisation of the hypothalamic activation.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •cluster headache in crisis
  • •no serious illnesses in progress as cancer, autoimmune disease, liver disease
  • •patient without chronic psychiatric disease excluding moderate and reactional depression
  • •no demential disease
  • •no anxious or depressive disease
  • •no contraindication to PET scan (pregnancy and breast-feeding)
  • •social security cover
  • •written informed consent

Exclusion Criteria

  • •No effective contraception taken
  • •unable to realize a decubitus of 15 minutes long

Outcomes

Primary Outcomes

To confirm the existence of a hypothalamic promoter at the origin of Spontaneous Cluster Headache Attacks

Time Frame: 2 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials